Gene · 6584
Papers1,762
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,762
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Newborn screening of primary carnitine deficiency: clinical and molecular genetic characteristics. | Ital J Pediatr | 2025 | 40069787 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Assessment of Pharmacokinetic Profile of Peramivir in the Context of Inhalation Therapy. | Pharmaceuticals (Basel) | 2025 | 40005995 | PubTator, text mining | PubMed |
| Structural and Dynamic Assessment of Disease-Causing Mutations for the Carnitine Transporter OCTN2. | Mol Inform | 2025 | 39811908 | PubTator, text mining | PubMed |
| Identification of Drug-Targetable Genes for Eczema and Dermatitis Using Integrated Genomic and Proteomic Approaches. | Dermatitis | 2025 | 39786806 | PubTator, text mining | PubMed |
| Exploring a novel model for newborn genetic screening in Ningxia, northern China: A retrospective observational study. | Medicine (Baltimore) | 2024 | 39969324 | PubTator, text mining | PubMed |
| Application of targeted high-throughput sequencing as a diagnostic tool for neonatal genetic metabolic diseases following tandem mass spectrometry screening. | Front Public Health | 2024 | 39776477 | PubTator, text mining | PubMed |
| Spectrum analysis of inborn errors of metabolism for expanded newborn screening in Xinjiang, China. | PeerJ | 2024 | 39670100 | PubTator, text mining | PubMed |
| Altered carnitine transporter genes (SLC22A5, SLC22A16, SLC6A14) expression pattern among lung cancer patients. | Transl Lung Cancer Res | 2024 | 39670016 | PubTator, text mining | PubMed |
| [Preimplantation genetic testing for a Chinese pedigree affected with Primary carnitine deficiency]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 39653356 | PubTator, text mining | PubMed |
| OCTN2 expression and function in the Sertoli cells of testes from patients with non-obstructive azoospermia. | J Mol Histol | 2024 | 39636482 | PubTator, text mining | PubMed |
| [Expanded carrier screening for 216 diseases in a cohort of 3 097 healthy Chinese individuals of childbearing age]. | Zhonghua Fu Chan Ke Za Zhi | 2024 | 39463360 | PubTator, text mining | PubMed |
| An extended substrate spectrum of the proton organic cation antiporter and relation to other cation transporters. | Basic Clin Pharmacol Toxicol | 2024 | 39429132 | PubTator, text mining | PubMed |
| Involvement of Proton-Coupled Organic Cation Antiporter in Human Blood-Brain Barrier Transport of Mesoridazine and Metoclopramide. | Biol Pharm Bull | 2024 | 39414441 | PubTator, text mining | PubMed |
| The Pharmacokinetics and Liver-Targeting Evaluation of Silybin Liposomes Mediated by the NTCP/OCTN2 Dual Receptors. | Mol Pharm | 2024 | 39370820 | PubTator, text mining | PubMed |
| Carnitine traffic and human fertility. | Biochem Pharmacol | 2024 | 39368751 | PubTator, text mining | PubMed |
| [Changes in the expression of genes related to intestinal fatty acid oxidation and carnitine metabolism in patients with ulcerative colitis]. | Zhonghua Yi Xue Za Zhi | 2024 | 39307717 | PubTator, text mining | PubMed |
| Contributions of multiple transport mechanisms to intestinal uptake of serotonin. | J Pharm Sci | 2024 | 39278593 | PubTator, text mining | PubMed |
| Incorporating Next-Generation Sequencing as a Second-Tier Test for Primary Carnitine Deficiency. | Mol Genet Genomic Med | 2024 | 39248612 | PubTator, text mining | PubMed |
| Diagnostic challenges and outcome of fatty acid oxidation defects in a tertiary care center in Lebanon. | Orphanet J Rare Dis | 2024 | 39210374 | PubTator, text mining | PubMed |
| The Human OCTN Sub-Family: Gene and Protein Structure, Expression, and Regulation. | Int J Mol Sci | 2024 | 39201429 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6584/papers?page=5